Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.

Leung DY, Gao PS, Grigoryev DN, Rafaels NM, Streib JE, Howell MD, Taylor PA, Boguniewicz M, Canniff J, Armstrong B, Zaccaro DJ, Schneider LC, Hata TR, Hanifin JM, Beck LA, Weinberg A, Barnes KC.

J Allergy Clin Immunol. 2011 Apr;127(4):965-73.e1-5. doi: 10.1016/j.jaci.2011.02.010. Erratum in: J Allergy Clin Immunol. 2011 Oct;128(4):833.

2.

Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.

Gao L, Bin L, Rafaels NM, Huang L, Potee J, Ruczinski I, Beaty TH, Paller AS, Schneider LC, Gallo R, Hanifin JM, Beck LA, Geha RS, Mathias RA, Barnes KC, Leung DY.

J Allergy Clin Immunol. 2015 Dec;136(6):1591-600. doi: 10.1016/j.jaci.2015.06.047. Epub 2015 Sep 3.

PMID:
26343451
3.

Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-γ-producing CD8+ T cells.

Mathias RA, Weinberg A, Boguniewicz M, Zaccaro DJ, Armstrong B, Schneider LC, Hata TR, Hanifin JM, Beck LA, Barnes KC, Leung DY.

Br J Dermatol. 2013 Sep;169(3):700-3. doi: 10.1111/bjd.12382.

PMID:
23600999
4.

Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.

Bin L, Edwards MG, Heiser R, Streib JE, Richers B, Hall CF, Leung DY.

J Allergy Clin Immunol. 2014 Oct;134(4):848-55. doi: 10.1016/j.jaci.2014.07.018. Epub 2014 Aug 23.

5.

Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.

Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):650-7. doi: 10.1038/jid.2011.374. Epub 2011 Nov 24.

6.

Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.

Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Barnes KC, Leung DY.

J Allergy Clin Immunol. 2009 Sep;124(3):507-13, 513.e1-7. doi: 10.1016/j.jaci.2009.07.034.

PMID:
19733298
7.

The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.

Howell MD, Gao P, Kim BE, Lesley LJ, Streib JE, Taylor PA, Zaccaro DJ, Boguniewicz M, Beck LA, Hanifin JM, Schneider LC, Hata TR, Gallo RL, Kaplan MH, Barnes KC, Leung DY.

J Allergy Clin Immunol. 2011 Nov;128(5):1006-14. doi: 10.1016/j.jaci.2011.06.003. Epub 2011 Jul 18.

8.

Specificity protein 1 is pivotal in the skin's antiviral response.

Bin L, Howell MD, Kim BE, Streib JE, Hall CF, Leung DY.

J Allergy Clin Immunol. 2011 Feb;127(2):430-438.e1-2. doi: 10.1016/j.jaci.2010.11.013. Epub 2011 Jan 5.

9.

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY.

J Allergy Clin Immunol. 2009 Aug;124(2):260-9, 269.e1-7. doi: 10.1016/j.jaci.2009.05.020. Epub 2009 Jun 27.

10.

Cathelicidin deficiency predisposes to eczema herpeticum.

Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, Pavicic T, Boguniewicz M, Leung DY.

J Allergy Clin Immunol. 2006 Apr;117(4):836-41. Epub 2006 Feb 14.

11.

Why is eczema herpeticum unexpectedly rare?

Leung DY.

Antiviral Res. 2013 May;98(2):153-7. doi: 10.1016/j.antiviral.2013.02.010. Epub 2013 Feb 22.

12.

IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.

Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DY.

J Invest Dermatol. 2013 Dec;133(12):2678-85. doi: 10.1038/jid.2013.223. Epub 2013 May 8.

13.

Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.

Broccardo CJ, Mahaffey S, Schwarz J, Wruck L, David G, Schlievert PM, Reisdorph NA, Leung DY.

J Allergy Clin Immunol. 2011 Jan;127(1):186-93, 193.e1-11. doi: 10.1016/j.jaci.2010.10.033.

14.

Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum.

Hinz T, Zaccaro D, Byron M, Brendes K, Krieg T, Novak N, Bieber T.

Allergy. 2011 Jul;66(7):925-33. doi: 10.1111/j.1398-9995.2010.02538.x. Epub 2011 Jan 24.

15.

Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions.

Takahashi R, Sato Y, Kurata M, Yamazaki Y, Kimishima M, Shiohara T.

J Immunol. 2014 Feb 1;192(3):969-78. doi: 10.4049/jimmunol.1300102. Epub 2013 Dec 30.

16.

Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.

Oyoshi MK, Beaupré J, Venturelli N, Lewis CN, Iwakura Y, Geha RS.

J Allergy Clin Immunol. 2015 Jun;135(6):1511-8.e6. doi: 10.1016/j.jaci.2014.12.1923. Epub 2015 Jan 30.

17.

Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.

Freyschmidt EJ, Mathias CB, MacArthur DH, Laouar A, Narasimhaswamy M, Weih F, Oettgen HC.

J Allergy Clin Immunol. 2007 Mar;119(3):671-9.

PMID:
17336617
18.

Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.

Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC.

J Allergy Clin Immunol. 2010 Jun;125(6):1403-1407.e4. doi: 10.1016/j.jaci.2010.03.016. Epub 2010 May 13. No abstract available.

19.

[Eczema herpeticum in a patient with atopic dermatitis, carrying r501x and 2282del4 filaggrin null mutations].

Valdés-Rodríguez R, Saavedra-Alanís VM, Islas-Aguilar MA, Torres-Álvarez B.

Gac Med Mex. 2015 Mar-Apr;151(2):252-5. Spanish.

20.

Genetic polymorphisms in the promoter of the interferon gamma receptor 1 gene are associated with atopic cataracts.

Matsuda A, Ebihara N, Kumagai N, Fukuda K, Ebe K, Hirano K, Sotozono C, Tei M, Hasegawa K, Shimizu M, Tamari M, Namba K, Ohno S, Mizuki N, Ikezawa Z, Shirakawa T, Hamuro J, Kinoshita S.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):583-9.

PMID:
17251453
Items per page

Supplemental Content

Write to the Help Desk